Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
128 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Westmead Hospital
Westmead, New South Wales, Australia
- Cancer Care Service, Hervey Bay Hospital
Urraween, Queensland, Australia
- Victoria Breast & Oncology Care
East Melbourne, Victoria, Australia
- Cabrini Malvern
Malvern, Victoria, Australia
- Breast Cancer Research Centre
Nedlands, Western Australia, Australia
- St Vincent'S Hospital Sydney
Darlinghurst, Australia
- Gosford Hospital
Gosford, Australia
- St John of God Murdoch Hospital
Murdoch, Australia
- Eastern Health - Maroondah Hospital
Ringwood East, Australia
- Suporte Nutricional E Quimioterapia
Fortaleza, Ceará, Brazil
- Centro de Avaliacao de Medicamentos E Especialidades de Pesquisa
Serra, Espírito Santo, Brazil
- Hospital Sao Rafael
Salvador, Estado de Bahia, Brazil
- Instituto Mario Penna
Belo Horizonte, Minas Gerais, Brazil
- Maternidade E Cirurgia Nossa Senhora Do Rocio
Campo Largo, Paraná, Brazil
- Hospital Das Clinicas - Universidade Federal Do Parana
Curitiba, Paraná, Brazil
- Centro de Tratamento Oncologico Ltda - Cto
Belém, Pará, Brazil
- Hospital Do Capibaribe
Recife, Pernambuco, Brazil
- Real Hospital Portugues de Beneficencia de Pernambuco
Recife, Pernambuco, Brazil
- Centro de Pesquisa Vencer & Oncolinca
Teresina, Piauí, Brazil
- Hospital de Clinicas de Porto Alegre
Barretos, Rio Grande do Sul, Brazil
- Oncosite-Centro de Pesquisa Clinica Em Oncologia
Ijuí, Rio Grande do Sul, Brazil
- Hospital Escola Da Universidade Federal de Pelotas
Pelotas, Rio Grande do Sul, Brazil
- Irmandade Da Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
- Pontificia Universidade Catolica Do Rio Grande Do Sul (pucrs) - Hospital Sao Lucas
Porto Alegre, Rio Grande do Sul, Brazil
- Hospital de Amor Amazonia
Porto Velho, Rondona, Brazil
- Centro Oncologico de Roraima
Boa Vista, Roraima, Brazil
- Clinica Supera
Chapecó, Santa Catarina, Brazil
- Clinica de Neoplasias Litoral - Itajai
Itajaí, Santa Catarina, Brazil
- Hospital de Cancer de Barretos
Barretos, São Paulo, Brazil
- Hospital Amaral Carvalho de Jau
Jaú, São Paulo, Brazil
- Centro de Pesquisa Clinica Em Hematologia E Oncologia
Santo André, São Paulo, Brazil
- Clinicia de Pesquisa E Centro de Estudos Em Oncologia Ginecologica E Mamaria
São Paulo, São Paulo, Brazil
- Instituto Brasileiro de Controle Do Cancer
São Paulo, São Paulo, Brazil
- Instituto Do Cancer Do Estado de San Paulo
São Paulo, São Paulo, Brazil
- Beijing Cancer Hospital
Beijing, Beijing Municipality, China
- Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
- Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
- the First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
- Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
- Hubei Cancer Hospital
Wuhan, Hubei, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Dec 2018
- Primary completion
- 30 Dec 2025
- Completion
- 30 Dec 2027
- Last update posted
- 9 May 2025
- Registered enrollment
- 575
- Registry id
- NCT03562637
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.